Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
393
datasets available to search
ShareScore release 0.9.0
Dataset results
393 results for “mRNA vaccine”
A Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV
ClinicalTrials.gov study NCT06564194. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Serology After BBIBP-CorV Inactivated Vaccine Combined With BNT62b2 mRNA Booster Vaccine
ClinicalTrials.gov study NCT05547802. IPD Sharing: NO. Countries: 1. Publications: 0.
Immunogenicity and Reactogenicity Following a Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNtech) and Two Adjuvanted Sub-unit Vaccines (SP/GSK) Administered in Adults Who Received 2 Doses of Pfize
ClinicalTrials.gov study NCT05124171. IPD Sharing: NO. Countries: 1. Publications: 0.
Immunogenicity and Reactogenicity of the Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfi
ClinicalTrials.gov study NCT05749926. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer
ClinicalTrials.gov study NCT06326736. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sequential Enhanced Safety Study of a Novel Coronavirus Messenger RNA (mRNA) Vaccine in Adults Aged 18 Years and Older.
ClinicalTrials.gov study NCT05568693. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Immunogenicity of RVM-V001 in Healthy Individuals Previously Vaccinated With BNT162b2 and mRNA-1273
ClinicalTrials.gov study NCT05420077. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants
ClinicalTrials.gov study NCT05831111. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-Vaccination
ClinicalTrials.gov study NCT07330440. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I/II Study to Evaluate a SARS-CoV-2 mRNA Vaccine in Healthy Adults
ClinicalTrials.gov study NCT05903118. IPD Sharing: NO. Countries: 1. Publications: 0.
Serologic Response to the SARS-CoV-2 (COVID-19) MRNA-1273 Vaccine in Select Subsets of Oncology Patients
ClinicalTrials.gov study NCT04854980. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy Adults
ClinicalTrials.gov study NCT06821126. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
An Observational Study of Moderna COVID-19 Bivalent Vaccines (Original and Omicron BA.4/BA.5) and 2023 Updated mRNA COVID-19 Vaccines (XBB.1.5)
ClinicalTrials.gov study NCT05765578. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess Long-term Outcomes of Myocarditis Following Administration of COVID-19 mRNA Vaccine (SPIKEVAX)
ClinicalTrials.gov study NCT06189053. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Serological Response to mRNA and Inactivated COVID-19 Vaccine in Health Care Workers in Hong Kong
ClinicalTrials.gov study NCT04898946. IPD Sharing: NO. Countries: 1. Publications: 0.
SARS-CoV-2 mRNA Vaccination in Patients With Hepatocellular Carcinoma Treated With Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT07341321. IPD Sharing: YES. Countries: 1. Publications: 0.
Clinical Study of XP-006 mRNA Vaccine for R/R B-NHL
ClinicalTrials.gov study NCT07334574. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 50 Years or Above
ClinicalTrials.gov study NCT07289542. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)
ClinicalTrials.gov study NCT05939596. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Post-Marketing Safety Study in Japan of Shock and Anaphylaxis After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine in Persons in at High Risk of Severe COVID-1
ClinicalTrials.gov study NCT05894499. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.